{
    "Trade/Device Name(s)": [
        "ThromboTek PSe"
    ],
    "Submitter Information": "R2 Diagnostics, Inc.",
    "510(k) Number": "K082631",
    "Predicate Device Reference 510(k) Number(s)": [
        "K913424"
    ],
    "Regulatory Class": "Class III",
    "Product Code(s)": [
        "GGP"
    ],
    "Summary Letter Date": "December 17, 2008",
    "Summary Letter Received Date": "November 20, 2008",
    "Submission Date": "November 19, 2008",
    "Regulation Number(s)": [
        "21 CFR 864.7290"
    ],
    "Regulation Name(s)": [
        "Factor Deficiency Test"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Protein S activity"
    ],
    "Specimen Type(s)": [
        "Human plasma",
        "Citrated human plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AMAX 200 analyzer",
        "Stago ST4 analyzer",
        "STart4 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Clotting assay",
        "Tissue factor pathway-based assay"
    ],
    "Methodologies": [
        "Functional activity measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for ThromboTek PSe tissue factor pathway-based clotting assay for quantitative determination of functional Protein S activity in human plasma",
    "Indications for Use Summary": "Intended for the quantitative determination of functional Protein S activity, such as when identifying inherited or acquired Protein S deficiency",
    "fda_folder": "Hematology"
}